Palvella Therapeutics, Inc. Operating Income
Palvella Therapeutics, Inc. (PVLA) reported Operating Income of -$21.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-04
- Palvella Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$21.41M.
- Palvella Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$14.86M.
- Palvella Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$11.30M.
- Palvella Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$10.18M.
- Palvella Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$38.60M.
- Palvella Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$14.10M.
- Palvella Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$11.87M.
- Palvella Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$43.47M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 13 month | Operating Income (Loss) 16 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.41M 10-Q · filed 2026-08-04 | -$36.26M 10-Q · filed 2026-08-04 | -$47.56M derived: sum of 3 quarters · filed 2026-08-04 | -$57.74M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2026-03-31 | -$14.86M 10-Q · filed 2026-05-07 | -$26.16M derived: sum of 2 quarters · filed 2026-05-07 | -$36.34M derived: sum of 3 quarters · filed 2026-05-07 | -$45.59M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-12-31 | -$11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$21.48M derived: sum of 2 quarters · filed 2026-03-31 | -$30.73M derived: sum of 3 quarters · filed 2026-08-04 | -$38.60M 10-K · filed 2026-03-31 | |||||||||
| 2025-09-30 | -$10.18M 10-Q · filed 2025-11-12 | -$19.43M derived: sum of 2 quarters · filed 2026-08-04 | -$27.30M 10-Q · filed 2025-11-12 | -$31.66M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-06-30 | -$9.25M 10-Q · filed 2026-08-04 | -$17.12M 10-Q · filed 2026-08-04 | -$21.49M derived: sum of 3 quarters · filed 2026-08-04 | -$26.55M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-03-31 | -$7.87M 10-Q · filed 2026-05-07 | -$12.24M derived: sum of 2 quarters · filed 2026-05-07 | -$17.30M derived: sum of 3 quarters · filed 2026-05-07 | -$20.21M derived: sum of 4 quarters · filed 2026-05-07 | |||||||||
| 2024-12-31 | -$4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.43M derived: sum of 2 quarters · filed 2026-03-31 | -$12.34M derived: sum of 3 quarters · filed 2026-03-31 | -$14.10M 10-K · filed 2026-03-31 | |||||||||
| 2024-09-30 | -$5.06M 10-Q · filed 2025-11-12 | -$3.13M 10-Q · filed 2024-11-13 | -$7.97M derived: sum of 2 quarters · filed 2025-11-12 | -$9.73M 10-Q · filed 2025-11-12 | -$12.62M 10-Q · filed 2024-11-13 | $3.66M derived: sum of 4 quarters · filed 2025-11-12 | |||||||
| 2024-06-30 | -$2.91M 10-Q · filed 2025-08-14 | -$4.18M 10-Q · filed 2024-08-14 | -$4.67M 10-Q · filed 2025-08-14 | -$9.48M 10-Q · filed 2024-08-14 | $8.72M derived: sum of 3 quarters · filed 2025-08-14 | -$3.09M derived: sum of 4 quarters · filed 2025-08-14 | |||||||
| 2024-03-31 | -$1.76M 10-Q · filed 2025-05-15 | -$5.30M 10-Q · filed 2024-05-15 | $11.63M derived: sum of 2 quarters · filed 2025-05-15 | -$180.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.88M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||
| 2023-12-31 | $13.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.58M derived: sum of 2 quarters · filed 2025-03-31 | $3.64M derived: sum of 3 quarters · filed 2025-03-31 | -$11.87M 10-K · filed 2025-03-31 | -$29.76M 10-K · filed 2024-03-29 | ||||||||
| 2023-09-30 | -$11.81M 10-Q · filed 2024-11-13 | -$9.74M derived: sum of 2 quarters · filed 2024-11-13 | -$25.25M 10-Q · filed 2024-11-13 | -$36.77M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2023-06-30 | $2.06M 10-Q · filed 2024-08-14 | -$13.45M 10-Q · filed 2024-08-14 | -$24.97M derived: sum of 3 quarters · filed 2024-08-14 | -$37.13M derived: sum of 4 quarters · filed 2024-08-14 | |||||||||
| 2023-03-31 | -$15.51M 10-Q · filed 2024-05-15 | -$27.03M derived: sum of 2 quarters · filed 2024-05-15 | -$39.20M derived: sum of 3 quarters · filed 2024-05-15 | -$51.53M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||
| 2022-12-31 | -$11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$23.69M derived: sum of 2 quarters · filed 2024-03-29 | -$36.02M derived: sum of 3 quarters · filed 2024-03-29 | -$43.47M 10-K · filed 2024-03-29 | |||||||||
| 2022-09-30 | -$12.17M 10-Q · filed 2023-11-14 | -$24.50M derived: sum of 2 quarters · filed 2023-11-14 | -$31.95M 10-Q · filed 2023-11-14 | -$42.95M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||
| 2022-06-30 | -$12.33M 10-Q · filed 2023-08-10 | -$19.79M 10-Q · filed 2023-08-10 | -$30.79M derived: sum of 3 quarters · filed 2023-08-10 | -$49.80M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||
| 2022-03-31 | -$7.46M 10-Q · filed 2023-05-11 | -$18.46M derived: sum of 2 quarters · filed 2023-05-11 | -$37.47M derived: sum of 3 quarters · filed 2023-05-11 | -$54.23M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||
| 2021-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$30.01M derived: sum of 2 quarters · filed 2023-03-31 | -$46.77M derived: sum of 3 quarters · filed 2023-03-31 | -$51.83M 10-K · filed 2023-03-31 | |||||||||
| 2021-09-30 | -$19.01M 10-Q · filed 2022-11-04 | -$35.77M derived: sum of 2 quarters · filed 2022-11-04 | -$40.83M 10-Q · filed 2022-11-04 | -$53.24M derived: sum of 4 quarters · filed 2022-11-04 | |||||||||
| 2021-06-30 | -$16.76M 10-Q · filed 2022-08-04 | -$21.82M 10-Q · filed 2022-08-04 | -$34.23M derived: sum of 3 quarters · filed 2022-08-04 | -$47.23M derived: sum of 4 quarters · filed 2022-08-04 | |||||||||
| 2021-03-31 | -$5.06M 10-Q · filed 2022-05-11 | -$17.47M derived: sum of 2 quarters · filed 2022-05-11 | -$30.47M derived: sum of 3 quarters · filed 2022-05-11 | -$35.12M derived: sum of 4 quarters · filed 2022-05-11 | |||||||||
| 2020-12-31 | -$12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$25.41M derived: sum of 2 quarters · filed 2022-03-02 | -$30.07M derived: sum of 3 quarters · filed 2022-03-02 | -$33.92M 10-K · filed 2022-03-02 | |||||||||
| 2020-09-30 | -$13.00M 10-Q · filed 2021-11-02 | -$17.65M derived: sum of 2 quarters · filed 2021-11-02 | -$21.51M 10-Q · filed 2021-11-02 | -$22.84M derived: sum of 4 quarters · filed 2021-11-02 | |||||||||
| 2020-06-30 | -$4.66M 10-Q · filed 2021-08-05 | -$8.51M 10-Q · filed 2021-08-05 | -$9.84M derived: sum of 3 quarters · filed 2021-08-05 | -$12.76M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||
| 2020-03-31 | -$3.86M 10-Q · filed 2021-05-17 | -$5.19M derived: sum of 2 quarters · filed 2021-05-17 | -$8.10M derived: sum of 3 quarters · filed 2021-05-17 | -$20.33M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||
| 2019-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.24M derived: sum of 2 quarters · filed 2021-03-31 | -$16.47M derived: sum of 3 quarters · filed 2021-03-31 | -$27.16M 10-K · filed 2021-03-31 | |||||||||
| 2019-09-30 | -$2.91M 10-Q · filed 2020-11-04 | -$15.14M derived: sum of 2 quarters · filed 2020-11-04 | -$25.83M 10-Q · filed 2020-11-04 | -$38.48M derived: sum of 4 quarters · filed 2020-11-04 | |||||||||
| 2019-06-30 | -$12.23M 10-Q · filed 2020-08-10 | -$22.91M 10-Q · filed 2020-08-10 | -$35.56M derived: sum of 3 quarters · filed 2020-08-10 | -$43.37M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||
| 2019-03-31 | -$10.68M 10-Q · filed 2020-05-11 | -$23.33M derived: sum of 2 quarters · filed 2020-05-11 | -$31.14M derived: sum of 3 quarters · filed 2020-05-11 | -$33.38M derived: sum of 4 quarters · filed 2020-05-11 | |||||||||
| 2018-12-31 | -$12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$20.45M derived: sum of 2 quarters · filed 2020-03-13 | -$22.70M derived: sum of 3 quarters · filed 2020-03-13 | -$30.83M 10-K · filed 2020-03-13 | |||||||||
| 2018-09-30 | -$7.80M 10-Q · filed 2019-11-12 | -$10.05M derived: sum of 2 quarters · filed 2019-11-12 | -$18.18M 10-Q · filed 2019-11-12 | -$11.70M derived: sum of 4 quarters · filed 2019-11-12 | |||||||||
| 2018-06-30 | -$2.24M 10-Q · filed 2019-08-09 | -$10.38M 10-Q · filed 2019-08-09 | -$3.89M derived: sum of 3 quarters · filed 2019-08-09 | -$9.07M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||
| 2018-03-31 | -$8.14M 10-Q · filed 2019-05-10 | -$1.65M derived: sum of 2 quarters · filed 2019-05-10 | -$6.83M derived: sum of 3 quarters · filed 2019-05-10 | -$14.72M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||
| 2017-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.30M derived: sum of 2 quarters · filed 2019-03-18 | -$6.59M derived: sum of 3 quarters · filed 2019-03-18 | -$14.59M 10-K · filed 2019-03-18 | |||||||||
| 2017-09-30 | -$5.18M 10-Q · filed 2018-11-07 | -$5.18M 10-Q · filed 2017-11-13 | -$13.07M derived: sum of 2 quarters · filed 2018-11-07 | -$21.08M 10-Q · filed 2018-11-07 | -$21.08M 10-Q · filed 2017-11-13 | -$27.49M derived: sum of 4 quarters · filed 2018-11-07 | |||||||
| 2017-06-30 | -$7.89M 10-Q · filed 2018-08-09 | -$7.89M 10-Q · filed 2017-08-11 | -$15.90M 10-Q · filed 2018-08-09 | -$15.90M 10-Q · filed 2017-08-11 | -$22.30M derived: sum of 3 quarters · filed 2018-08-09 | -$28.48M derived: sum of 4 quarters · filed 2018-08-09 | |||||||
| 2017-03-31 | -$8.01M 10-Q · filed 2018-05-10 | -$8.01M 10-Q · filed 2017-05-15 | -$14.41M derived: sum of 2 quarters · filed 2018-05-10 | -$20.59M derived: sum of 3 quarters · filed 2018-05-10 | -$26.38M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||
| 2016-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$12.58M derived: sum of 2 quarters · filed 2018-03-15 | -$18.38M derived: sum of 3 quarters · filed 2018-03-15 | -$22.76M 10-K · filed 2018-03-15 | -$22.76M 10-K · filed 2017-03-30 | ||||||||
| 2016-09-30 | -$6.18M 10-Q · filed 2017-11-13 | -$11.97M derived: sum of 2 quarters · filed 2017-11-13 | -$16.35M 10-Q · filed 2017-11-13 | -$18.92M derived: sum of 4 quarters · filed 2017-11-13 | |||||||||
| 2016-06-30 | -$5.80M 10-Q · filed 2017-08-11 | -$10.18M 10-Q · filed 2017-08-11 | -$12.74M derived: sum of 3 quarters · filed 2017-08-11 | -$16.62M derived: sum of 4 quarters · filed 2017-08-11 | |||||||||
| 2016-03-31 | -$4.38M 10-Q · filed 2017-05-15 | -$6.95M derived: sum of 2 quarters · filed 2017-05-15 | -$10.83M derived: sum of 3 quarters · filed 2017-05-15 | -$14.36M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||
| 2015-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$6.45M derived: sum of 2 quarters · filed 2017-03-30 | -$9.98M derived: sum of 3 quarters · filed 2017-03-30 | -$13.68M 10-K · filed 2017-03-30 | |||||||||
| 2015-09-30 | -$3.88M 10-Q · filed 2016-11-10 | -$7.41M derived: sum of 2 quarters · filed 2016-11-10 | -$11.12M 10-Q · filed 2016-11-10 | -$13.03M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||
| 2015-06-30 | -$3.53M 10-Q · filed 2016-08-11 | -$7.24M 10-Q · filed 2016-08-11 | -$9.15M derived: sum of 3 quarters · filed 2016-08-11 | -$10.99M derived: sum of 4 quarters · filed 2016-08-11 | |||||||||
| 2015-03-31 | -$3.70M 10-Q · filed 2016-05-12 | -$5.62M derived: sum of 2 quarters · filed 2016-05-12 | -$7.46M derived: sum of 3 quarters · filed 2016-05-12 | -$10.23M derived: sum of 4 quarters · filed 2016-05-12 | |||||||||
| 2014-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$3.76M derived: sum of 2 quarters · filed 2016-03-23 | -$6.53M derived: sum of 3 quarters · filed 2016-03-23 | -$7.20M 10-K · filed 2016-03-23 | -$7.20M 10-K · filed 2015-03-30 | ||||||||
| 2014-09-30 | -$1.84M 10-Q · filed 2015-11-13 | -$13.92K 10-Q · filed 2014-11-13 | -$4.61M derived: sum of 2 quarters · filed 2015-11-13 | -$5.28M 10-Q · filed 2015-11-13 | -$5.28M derived: sum of 4 quarters · filed 2015-11-13 | -$29.90K 10-Q · filed 2014-12-12 | |||||||
| 2014-06-30 | -$2.77M 10-Q · filed 2015-08-13 | -$3.44M 10-Q · filed 2015-08-13 | -$3.44M derived: sum of 3 quarters · filed 2015-08-13 | -$15.71K 10-K · filed 2014-09-12 | -$15.99K 10-K · filed 2014-09-12 | ||||||||
| 2014-03-31 | -$671.22K 10-Q · filed 2015-05-14 | -$1.54K 10-Q · filed 2014-06-02 | -$673.41K derived: sum of 2 quarters · filed 2015-05-14 | -$9.50K 10-Q · filed 2014-06-02 | -$9.50K 10-Q · filed 2014-06-02 | ||||||||
| 2013-12-31 | -$2.20K 10-Q · filed 2014-05-14 | -$7.96K 10-Q · filed 2014-05-14 | -$7.96K 10-Q · filed 2014-05-14 | $553.83K 10-K · filed 2015-03-30 | |||||||||
| 2013-09-30 | -$5.76K 10-Q · filed 2014-12-12 | ||||||||||||
| 2013-06-30 | -$274.00 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |